Monograph
D01AC10 - Bifonazole |
Propably not porphyrinogenic |
PNP |
Rationale
Inhibitor of CYPs 17 (potent), C19 (aromatase), 2E1, 11B1 and 3A4. Probably insignificant systemic exposure.
Chemical description
Imidazole antimycotic for dermatological use (creme 1%). Inhibitor of several CYPs. Systemic absorbtion from the skin is very low; 0.6-0.8 %.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Mycospor · Mycospor, creme o/w 10 mg/gBelgium
Canestene Derm · Canestene Derm 1 % crèmeUnited Kingdom
Canesten Bifonazole Once Daily Athlete's Foot · Canesten Bifonazole Once Daily Athlete's Foot 1% creamPoland
Canespor · Steper proLuxembourg
Canestene DermFinland
CanesporSerbia
Canespor · Canespor®
© NAPOS 2024